Zobrazeno 1 - 10
of 31
pro vyhledávání: '"E Tomero Muriel"'
Autor:
I Rua-Figueroa, L Inês, N Jimenez, M Galindo, I Hernández, C Mouriño, JM Pego-Reigosa, I Altabás González, E Uriarte Isacelaya, I Carrión-Barberà, F Rubiño Juarez, R Almagro, E Tomero Muriel, T Salman, M Rodríguez Almaraz
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/ae2a4dc6fd434a59a90bfe7ee12f0e09
Autor:
J Narvaez, FJ López-Longo, C Galisteo, JA Hernandez-Beriain, A Olive, I Rua-Figueroa, E Raya, I Castellvi, A Fernández-Nebro, R Blanco, J Calvo-Alén, J Ibáñez, C Marras, A Boteanu, V Martínez-Taboada, JL Andreu, JM Pego-Reigosa, B Hernández-Cruz, E Uriarte Isacelaya, E Tomero Muriel, E Díez Álvarez, C Moriano, C Bermúdez, M Galindo-Izquierdo, M Freire González, O Fernández-Berrizbeitia, A Pérez Gómez, C Montilla-Morales, G Santos Soler, M Rodríguez-Gómez, P Vela-Casasempere, L Expósito, R Menor-Almagro, M Ibañez-Barceló, V Quevedo Vila, T Vázquez Rodríguez
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/3de8ad8238cc4479a39d5a2eacd04312
Autor:
I Altabás González, Í Rúa-Figueroa, F Rubiño Juarez, C Mouriño, I Hernández, R Almagro, E Uriarte Isacelaya, E Tomero Muriel, T Salman, I Carrión-Barberà, M Galindo, M Rodríguez Almaraz, N Jiménez, L Inês, JM Pego-Reigosa
Publikováno v:
Friday 07 October 2022 from 13:00 to 14:10.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
I. Altabás González, I. Rua-Figueroa, N. Jiménez, F. Rubiño, C. Mouriño Rodríguez, I. Hernández, R. Menor-Almagro, E. Uriarte Isacelaya, E. Tomero Muriel, T. C. Salman Monte, I. Carrión Barberà, M. Galindo, E. Rodríguez Almaraz, L. Inês, J. M. Pego-Reigosa
Publikováno v:
Annals of the Rheumatic Diseases. 81:665.3-666
BackgroundTreat to Target strategies are necessary in Systemic Lupus Erythematosus (SLE). They are difficult to establish due to the heterogeneity of the disease. The current definitions of Lupus Low Disease Activity State (LLDAS) according to the As
Autor:
José M. Pego-Reigosa, E. Tomero Muriel, E. Uriarte Isacelaya, Elia Valls-Pascual, Elena Aurrecoechea, Iñigo Rúa-Figueroa, I. Jiménez-Moleón, J.A. Narváez, N. Lozano Rivas, Raúl Menor-Almagro, Eduardo Salas, Miriam Moreno, Alina Boteanu, T. R. Vazquez Rodriguez, Lorena Expósito, V. Quevedo Vila, C. A. Montilla-Morales, Antonio Fernández-Nebro, C. Mouriño, Jaime Calvo-Alén, M. Freire González, Gemma Bonilla, J.A. Bernal, Cristina Bohórquez, Tatiana Cobo-Ibáñez, Arantxa Mas, ML Velloso Feijoo, J. A. Hernandez Beriain, Roman Blanco, O. Ibarguengoitia, D. Rua-Figueroa, E. Salgado Perez, J.L. Andreu Sánchez, N. Pérez-Veiga, A. Pecondon, C. Sanguesa, María Galindo-Izquierdo, F. J. Toyos Sáenz de Miera, A. M. Anzola Alfaro, N. Del-Val
Publikováno v:
Annals of the Rheumatic Diseases. 80:610-611
Background:Factors associated with the development of chronic heart failure (CHF) in systemic lupus erythematosus (SLE) have received little attention. On the other hand, recent data from the use of hydroxychloroquine in the treatment of SARS-CoV-2 i
Autor:
I. Llorente, S. Castañeda, R. Garcia de Vicuna, C. Valero, J. P. Baldivieso, Isidoro González-Álvaro, E. Tomero Muriel
Publikováno v:
Annals of the Rheumatic Diseases. 80:719.2-719
Background:Biological therapy in combination is discouraged in the guidelines for the treatment of immune-mediated inflammatory diseases, attending to safety reasons. However, combined biological therapy could be a valid alternative in patients with
Autor:
Marcelino Revenga, Vanesa Calvo-Río, José L. Hernández, Elia Valls-Pascual, Santos Castañeda, Ricardo Blanco, M. Fernández, M. A. González-Gay, R. Veroz Gonzalez, F. J. Toyos Sáenz de Miera, Andrés Mora, O. Maiz-Alonso, Monica Calderón-Goercke, Arantxa Conesa, Beatriz Valls-Espinosa, Verónica Rodriguez-Mendez, Valvanera Pinillos, Diana Peiteado, José Luis Martín-Varillas, Belén Atienza-Mateo, Vega Jovani, I. González-Mazón, Ana Blanco, E. Tomero Muriel, Ángel García-Aparicio, Elena Aurrecoechea, R. Demetrio-Pablo, I. Torre-Salaberri, Diana Prieto-Peña, Juan A. Troyano, L. Sanchez-Bilbao, Margarita Sánchez-Orgaz, D. Martínez-López
Publikováno v:
Annals of the Rheumatic Diseases. 79:850-851
Background:Tocilizumab (TCZ) has shown promising results in the treatment of inflammatory ocular disease, especially in uveitis (1-3). Graves orbitopathy (GO) is the most common complication of Graves’ disease (GD). Conventional immunosuppressive d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Jiménez Borreguero, E. Tomero Muriel, F. Alfonso Manterola, Santos Castañeda, Esther Vicente, J.P. Lopez-Bote, A. Humbría, C. Rodríguez-López, Isidoro González-Álvaro, R. Garcia de Vicuna, L. Vega
Publikováno v:
Annals of the Rheumatic Diseases. 79:746.1-746
Background:Ankylosing spondylitis (AS) has been associated with different comorbidities, particularly some of cardiac origin. Recently, some studies have been published that suggest that certain arrhythmias may be more frequent in AS than in the gene